Nav: Home

Center for Regenerative Medicine receives 3 prestigious NIH awards

November 14, 2016

BOSTON--The Center for Regenerative Medicine (CReM) at Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) has received three prestigious awards from the National Institutes of Health (NIH) to further its commitment to induced pluripotent stem cell (iPSC) research and education.

Created from a patient's skin or blood cells, iPSCs have the potential to form any type of cell, providing a potentially inexhaustible source of patient cells for biomedical research, thus opening the door for patient-specific medicine.

Two of the NIH awards, totaling $5 million, will support a new National Heart, Lung, and Blood Institute (NHLBI) initiative called the Progenitor Cell Translational Consortium which aims to develop stem cell-based treatments for heart, lung and blood diseases. CReM, which is the only institution to receive two of these prestigious awards nationally, will focus on how gene-editing and cell-based therapies can be used for treatment of pulmonary diseases.

"We are honored to receive these awards which will allow us to gain greater understanding about how we treat the most medically complex cases and improve our patient's lives," said Darrell Kotton, MD, director of CReM and Seldin Professor of Medicine at BUSM who will serve as co-principal investigator of the projects, together with investigators from Cincinnati Children's Hospital, University of Pennsylvania, and UCSF.

Additionally, CReM and the Boston University (BU) Clinical and Transitional Science Institute (CTSI) received a $4.1 million NCATS award to form a national CTSA network for iPSCs banking, sharing and training. The consortium, which will be led by BU principal investigators Kotton and Dr. Andrew Wilson, Assistant Professor of Medicine, will include researchers from the University of Pennsylvania, Harvard University and the University of Chicago.

"The discovery of iPSCs provides an unprecedented opportunity for any scientist to derive an inexhaustible supply of patient-derived primary cells. These cells, which contain each patient's own genetic background, can now be applied for in vitro human disease modeling, drug screening of personalized therapeutics, drug screening for unknown side effects and the development of future regenerative cell-based therapies," said David Center, MD, the Gordon and Ruth Snider Professor of Pulmonary Medicine and Chief of the division of Pulmonary, Allergy, Sleep and Critical Care medicine at BMC and Director of the Clinical and Translational Science Institute at BU.

"Coupled with another $2.1 million CTSI award for training individuals in iPSC technology, we have the opportunity to make an impact on patient's lives for many years to come."

The consortium aims to make patient-derived iPSCs, along with the tools and expertise for their genetic manipulation, available to the greater research community on a large scale with the goal of understanding these complex diseases and developing potential therapies.

To achieve this goal, researchers propose sharing more than 1,000 iPSCs lines-- already derived by the teams taking part in the consortium--nationwide to both basic and clinical researchers; developing and supporting a formalized education and training program for other researchers; and supporting the maintenance and sharing of gene-editing tools and gene-edited iPSCs lines that will enable scientists to manipulate the human genome at will.

Each team will be led by researchers who have championed "open source biology". The approach encourages researchers to freely share iPSCs lines and their reprogramming reagents with others in the field. To date, the group is working with more than 500 labs across the globe.
About Boston Medical Center

Boston Medical Center is a private, not-for-profit, 487-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. It is the largest and busiest provider of trauma and emergency services in New England. Committed to providing high-quality health care to all, the hospital offers a full spectrum of pediatric and adult care services including primary and family medicine and advanced specialty care with an emphasis on community-based care. Boston Medical Center offers specialized care for complex health problems and is a leading research institution, receiving more than $119 million in sponsored research funding in fiscal year 2015. It is the 11th largest recipient of funding in the U.S. from the National Institutes of Health among independent hospitals. In 1997, BMC founded Boston Medical Center Health Plan, Inc., now one of the top ranked Medicaid MCOs in the country, as a non-profit managed care organization. It does business in Massachusetts as BMC HealthNet Plan and as Well Sense Health Plan in New Hampshire, serving more than 315,000 people, collectively. Boston Medical Center and Boston University School of Medicine are partners in the Boston HealthNet - 13 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit

Boston University Medical Center

Related Regenerative Medicine Articles:

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.
New research into stem cell mutations could improve regenerative medicine
Research from the University of Sheffield has given new insight into the cause of mutations in pluripotent stem cells and potential ways of stopping these mutations from occurring.
Keratin scaffolds could advance regenerative medicine and tissue engineering for humans
Researchers at Mossakowski Medical Research Center of the Polish Academy of Science have developed a simple method for preparing 3D keratin scaffold models which can be used to study the regeneration of tissue.
New prize-winning research highlights potential of immune intervention in improving regenerative medicine
Joana Neves is the 2019 grand prize winner of the Sartorius & Science Prize for Regenerating Medicine & Cell Therapy, for work in mice that offers a promising approach to improve the outcome of regenerative stem cell-based therapies aimed at delaying age-related degenerative diseases.
NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.
A new material for regenerative medicine capable to control cell immune response
Scientists of Tomsk Polytechnic University jointly with the University of Montana (USA) proposed a new promising material for regenerative medicine for recovery of damaged tissues and blood vessels.
Optoceutics: A new technique using light for regenerative medicine
Researchers in Italy at IIT-Istituto Italiano di Tecnologia used visible light together with photo-sensitive and biocompatible materials to facilitate the formation of new blood vessels in vitro.
Major stem cell discovery to boost research into development and regenerative medicine
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells.
Spinning-prism microscope helps gather stem cells for regenerative medicine
Pluripotent stem cells are crucial to regenerative medicine, but better screening methods are needed to isolate safe and effective cells for medical use.
'Cellular dust' provides new hope for regenerative medicine
While stem cells have the most therapeutic potential, the benefits of regenerative medicine may best be mobilised using extracellular vesicles (EVs), also known in the past as 'cellular dust'.
More Regenerative Medicine News and Regenerative Medicine Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at     You can read The Transition Integrity Project's report here.